Cite

HARVARD Citation

    Yu, A. et al. (2016). Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2‐Positive Metastatic Breast Cancer. Oncologist. pp. 418-424. [Online]. 
  
Back to record